Journal
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
Volume 2020, Issue -, Pages -Publisher
HINDAWI LTD
DOI: 10.1155/2020/9568647
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81503421, 81673722]
- Special Funds for Funding Funds of Fundamental Research Business Fees of Central Public Welfare Research Institutions [JDZX2015248]
- Key Scientific Research Projects of Higher Education Institutions in Henan Province [18A320005, 19A360032]
- Young Elite Scientists Sponsorship Program by CAST [2017QNRC001]
Ask authors/readers for more resources
Cardiovascular disease is one of the main human health risks, and the incidence is increasing. Salidroside is an important bioactive component of Rhodiola rosea L., which is used to treat Alzheimer's disease, tumor, depression, and other diseases. Recent studies have shown that salidroside has therapeutic effects, to some degree, in cardiovascular diseases via an antioxidative mechanism. However, evidence-based clinical data supporting the effectiveness of salidroside in the treatment of cardiovascular diseases are limited. In this review, we discuss the effects of salidroside on cardiovascular risk factors and cardiovascular diseases and highlight potential antioxidant therapeutic strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
